Accordingly, activation of GPR30 has clinical value in the protecting brain tissue, and GPR30 also provides new ideas for estrogen replacement therapy in cerebral ischemia (Prossnitz et al., 2008). Here, GPER1 is linked to Cerebral ischemia.